Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Lung Function and Symptom Response to Dupilumab in Type 2-Inflamed Chronic Obstructive Pulmonary Disease Across the Full Spectrum of Airflow Limitation: An Italian Multicentre Retrospective Cohort Study

NCT07788092 is registered in ClinicalTrials.gov with Azienda Ospedaliera di Perugia as lead sponsor.

NCT NCT07788092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07788092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Lung Function and Symptom Response to Dupilumab in Type 2-Inflamed Chronic Obstructive Pulmonary Disease Across the Full Spectrum of Airflow Limitation: An Italian Multicentre Retrospective Cohort Study
Lead sponsor
Azienda Ospedaliera di Perugia
Phase
Observational
Overall status
Completed
Start date
October 1, 2024
Completion date
April 30, 2026
Enrollment
40 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

copd, copd (chronic obstructive pulmonary disease), eosinophilia